Author Correction: Impact of KRAS mutation status on the efficacy of immunotherapy in lung cancer brain metastases (Scientific Reports, (2021), 11, 1, (18174), 10.1038/s41598-021-97566-z)

Adam Lauko; Rupesh Kotecha; Addison Barnett; Hong Li; Vineeth Tatineni; Assad Ali; Pradnya Patil; Alireza M. Mohammadi; Samuel T. Chao; Erin S. Murphy; Lilyana Angelov; John H. Suh; Gene H. Barnett; Nathan A. Pennell; Manmeet S. Ahluwalia

doi:10.1038/s41598-022-05489-0

Author Correction: Impact of KRAS mutation status on the efficacy of immunotherapy in lung cancer brain metastases (Scientific Reports, (2021), 11, 1, (18174), 10.1038/s41598-021-97566-z)

Adam Lauko
, Rupesh Kotecha
, Addison Barnett
, Hong Li
, Vineeth Tatineni
, Assad Ali
, Pradnya Patil
, Alireza M. Mohammadi
, Samuel T. Chao
, Erin S. Murphy
, Lilyana Angelov
, John H. Suh
, Gene H. Barnett
, Nathan A. Pennell
, Manmeet S. Ahluwalia

Research output: Contribution to journal › Comment/debate › peer-review

Original language	English
Article number	1147
Journal	Scientific Reports
Volume	12
Issue number	1
DOIs	https://doi.org/10.1038/s41598-022-05489-0
State	Published - Dec 2022

ASJC Scopus Subject Areas

General

Access to Document

10.1038/s41598-022-05489-0

Cite this

Lauko, A., Kotecha, R., Barnett, A., Li, H., Tatineni, V., Ali, A., Patil, P., Mohammadi, A. M., Chao, S. T., Murphy, E. S., Angelov, L., Suh, J. H., Barnett, G. H., Pennell, N. A., & Ahluwalia, M. S. (2022). Author Correction: Impact of KRAS mutation status on the efficacy of immunotherapy in lung cancer brain metastases (Scientific Reports, (2021), 11, 1, (18174), 10.1038/s41598-021-97566-z). Scientific Reports, 12(1), Article 1147. https://doi.org/10.1038/s41598-022-05489-0

Author Correction: Impact of KRAS mutation status on the efficacy of immunotherapy in lung cancer brain metastases (Scientific Reports, (2021), 11, 1, (18174), 10.1038/s41598-021-97566-z). / Lauko, Adam; Kotecha, Rupesh; Barnett, Addison et al.
In: Scientific Reports, Vol. 12, No. 1, 1147, 12.2022.

Research output: Contribution to journal › Comment/debate › peer-review

Lauko, A, Kotecha, R, Barnett, A, Li, H, Tatineni, V, Ali, A, Patil, P, Mohammadi, AM, Chao, ST, Murphy, ES, Angelov, L, Suh, JH, Barnett, GH, Pennell, NA & Ahluwalia, MS 2022, 'Author Correction: Impact of KRAS mutation status on the efficacy of immunotherapy in lung cancer brain metastases (Scientific Reports, (2021), 11, 1, (18174), 10.1038/s41598-021-97566-z)', Scientific Reports, vol. 12, no. 1, 1147. https://doi.org/10.1038/s41598-022-05489-0

@article{82b4ebbbe55d4340ae3dfe8b3bd9c538,

title = "Author Correction: Impact of KRAS mutation status on the efficacy of immunotherapy in lung cancer brain metastases (Scientific Reports, (2021), 11, 1, (18174), 10.1038/s41598-021-97566-z)",

author = "Adam Lauko and Rupesh Kotecha and Addison Barnett and Hong Li and Vineeth Tatineni and Assad Ali and Pradnya Patil and Mohammadi, \{Alireza M.\} and Chao, \{Samuel T.\} and Murphy, \{Erin S.\} and Lilyana Angelov and Suh, \{John H.\} and Barnett, \{Gene H.\} and Pennell, \{Nathan A.\} and Ahluwalia, \{Manmeet S.\}",

note = "Publisher Copyright: {\textcopyright} 2022, The Author(s).",

year = "2022",

month = dec,

doi = "10.1038/s41598-022-05489-0",

language = "English",

volume = "12",

journal = "Scientific Reports",

issn = "2045-2322",

number = "1",

}

TY - JOUR

T1 - Author Correction

T2 - Impact of KRAS mutation status on the efficacy of immunotherapy in lung cancer brain metastases (Scientific Reports, (2021), 11, 1, (18174), 10.1038/s41598-021-97566-z)

AU - Lauko, Adam

AU - Kotecha, Rupesh

AU - Barnett, Addison

AU - Li, Hong

AU - Tatineni, Vineeth

AU - Ali, Assad

AU - Patil, Pradnya

AU - Mohammadi, Alireza M.

AU - Chao, Samuel T.

AU - Murphy, Erin S.

AU - Angelov, Lilyana

AU - Suh, John H.

AU - Barnett, Gene H.

AU - Pennell, Nathan A.

AU - Ahluwalia, Manmeet S.

PY - 2022/12

Y1 - 2022/12

UR - https://www.scopus.com/pages/publications/85123072900

UR - https://www.scopus.com/pages/publications/85123072900#tab=citedBy

U2 - 10.1038/s41598-022-05489-0

DO - 10.1038/s41598-022-05489-0

M3 - Comment/debate

C2 - 35039661

AN - SCOPUS:85123072900

SN - 2045-2322

VL - 12

JO - Scientific Reports

JF - Scientific Reports

IS - 1

M1 - 1147

ER -

Author Correction: Impact of KRAS mutation status on the efficacy of immunotherapy in lung cancer brain metastases (Scientific Reports, (2021), 11, 1, (18174), 10.1038/s41598-021-97566-z)

ASJC Scopus Subject Areas

Access to Document

Other files and links

Cite this